Abstract
The aim of this study was to correlate magnetic resonance spectroscopy (MRS) measurements, including that for the N-acetyl aspartate (NAA)/creatine (Cr) ratio in the vermis (denoted V-NAA), right cerebellar hemisphere (R-NAA), and left (L-NAA) cerebellar hemisphere, with the clinical scale for the assessment and rating of ataxia (SARA) score for patients with spinocerebellar ataxia (SCA) types 2, 3, and 6. A total of 24 patients with SCA2, 48 with SCA3, and 16 with SCA6 were recruited; 12 patients with SCA2, 43 with SCA3, and 8 with SCA6 underwent detailed magnetic resonance neuroimaging. Forty-four healthy, age-matched individuals without history of neurologic disease served as control subjects. V-NAA and patient age were used to calculate the predicted age at which a patient with SCA2 or SCA3 would reach an onset V-NAA value. Results showed the following: the NAA/Cr ratio decreased with increasing age in patients with SCA but not in control subjects; the SARA score increased progressively with age and duration of illness; V-NAA showed a better correlation with SARA score than R-NAA in patients with SCA2 or SCA3; the ratio of age to V-NAA correlated well with CAG repeat number; the retrospectively predicted age of onset for SCA2 and SCA3 was consistent with patient-reported age of onset; R-NAA showed a better correlation with SARA score than V-NAA in patients with SCA6; V-NAA and R-NAA correlated with clinical severity (SARA score) in patients with SCA. The correlation between CAG repeat number and age could be expressed as a simple linear function, which might explain previous observations claiming that the greater the CAG repeat number, the earlier the onset of illness and the faster the disease progression. These findings support the use of MRS values to predict age of disease onset and to retrospectively evaluate the actual age of disease onset in SCA.
Highlights
Spinocerebellar ataxia (SCA) comprises a spectrum of progressive autosomal-dominant neurodegenerative disorders that typically progress over a period of 10 to 20 years, eventually resulting in poor quality of life and a shortened lifespan
The R-Nacetyl aspartate (NAA) ratio decreased with increasing age (r = –0.352, P,0.05), but the left hemisphere NAA (L-NAA) and vermis NAA/Cr ratio (V-NAA) ratios exhibited no obvious change with age (Table 2)
In patients with SCA3, all NAA ratios decreased with increasing age (Table 2)
Summary
Spinocerebellar ataxia (SCA) comprises a spectrum of progressive autosomal-dominant neurodegenerative disorders that typically progress over a period of 10 to 20 years, eventually resulting in poor quality of life and a shortened lifespan. One common mutation in patients with SCA1, SCA2, SCA3, SCA6, or SCA17 is an expanded CAG repeat sequence in the human ATXN1, ATXN2, ATXN3, CACNA1A, and TBP genes, respectively. The length of this CAG repeat expansion has been shown to correlate with the age of disease onset in these patients [1]. The prevalence of SCA2 is approximately 1 to 2 individuals in 100,000 [1] and is characterized by a marked loss of Purkinje neurons in the cerebellar cortex, as well as a loss of myelinated fibers in the inferior and middle cerebellar peduncles and cerebellar white matter [2]. Its pathology is characterized mainly by degeneration of Purkinje neurons in the cerebellar cortex, whereas the dentate nucleus, deep cerebellar white matter, and cerebellar peduncles remain unaffected [4,5]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
